Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Human vaginal metagenome

ABSTRACT: Vaginal microbiome in a high risk PTB cohort

PROVIDER: PRJNA300860 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR3510310.fastq.gz	Fastqsanger.gz
	SRR3510320.fastq.gz	Fastqsanger.gz
	SRR3510350.fastq.gz	Fastqsanger.gz
	SRR3510360.fastq.gz	Fastqsanger.gz
	SRR3510370.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 162

Similar Datasets

Project description:Vaginal microbiome in a high risk PTB cohort

| PRJNA321729 | ENA

human vaginal metagenome

Project description:Vaginal microbiome

| PRJNA1057978 | ENA

human vaginal metagenome

Project description:Menstrual cups, maturation of the adolescent vaginal microbiome, and STI/HIV risk

| PRJNA564566 | ENA

human vaginal metagenome

Project description:Menstrual cups, maturation of the adolescent vaginal microbiome, and STI/HIV risk

| PRJNA540529 | ENA

The Dynamics of the Vaginal Microbiome During Infertility Therapy with In Vitro Fertilization-Embryo Transfer

Project description:Clinical treatment protocols for infertility with in vitro fertilization-embryo transfer (IVF-ET) provide a unique opportunity to assess the human vaginal microbiome in defined hormonal milieu. Herein, we have investigated the association of circulating ovarian-derived estradiol (E2) and progesterone (P4) concentrations to the vaginal microbiome. Thirty IVF-ET patients were enrolled in this study, after informed consent. Blood was drawn at four time points during the IVF-ET procedure. In addition, if a pregnancy resulted, blood was drawn at 4-to-6 weeks of gestation. The serum concentrations of E2 and P4 were measured. Vaginal swabs were obtained in different hormonal milieu. Two independent genome-based technologies (and the second assayed in two different ways) were employed to identify the vaginal microbes. The vaginal microbiome underwent a transition with a decrease in E2 (and/or a decrease in P4). Novel bacteria were found in the vagina of 33% of the women undergoing IVF-ET. Our approach has enabled the discovery of novel, previously unidentified bacterial species in the human vagina in different hormonal milieu. While the relationship of hormone concentration and vaginal microbes was found to be complex, the data support a shift in the microbiome of the human vagina during IVF-ET therapy using standard protocols. The data also set the foundation for further studies examining correlations between IVF-ET outcome and the vaginal microbiome within a larger study population.

2011-10-24 | E-MEXP-2958 | biostudies-arrayexpress

human vaginal metagenome

Project description:Human vaginal microbiome (PRJCA019855)

| PRJDB38283 | ENA

human vaginal metagenome

Project description:Human associated vaginal microbiome Metagenome

| PRJNA549661 | ENA

human vaginal metagenome

Project description:Smoking and the Vaginal Microbiome

| PRJNA391039 | ENA

human vaginal metagenome

Project description:Vaginal microbiome of Canadian women